Masson, Rahul
Seivright, Justine
Grogan, Tristan
Atluri, Swetha
Hamzavi, Iltefat
Hogeling, Marcia
Shi, Vivian Y.
Hsiao, Jennifer L.
Article History
Received: 3 April 2024
Accepted: 4 June 2024
First Online: 22 June 2024
Declarations
:
: Jennifer L. Hsiao is on the Board of Directors for the Hidradenitis Suppurativa Foundation and has served as a consultant for AbbVie, Aclaris, Boehringer Ingelheim, and Novartis, as a speaker for AbbVie, and as an investigator for Amgen, Aristea, Boehringer Ingelheim, and Incyte. Jennifer L. Hsiao is an editorial board member of <i>Dermatology and Therapy</i>. Jennifer L. Hsiao was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions. Vivian Y. Shi is on the board of directors for the Hidradenitis Suppurativa Foundation (HSF), is an advisor for the National Eczema Association, is a stock shareholder of Learn Health, and has served as an advisory board member, investigator, or speaker for and/or received research funding from Sanofi Genzyme, Regeneron, AbbVie, Genentech, Eli Lilly, Novartis, SUN Pharma, LEO Pharma, Pfizer, Incyte, Boehringer Ingelheim, Almirall, Alumis, Aristea Therapeutics, Menlo Therapeutics, Dermira, Burt’s Bees, Galderma, Kiniksa, UCB, Bain Capital, Target-PharmaSolutions, Altus Lab/cQuell, MYOR, Polyfins Technology, GpSkin, and Skin Actives Scientific. Iltefat Hamzavi has served as a consultant to Abbvie, Pfizer, Incyte,UCB,Boerhinger Ingelheim, Sonoma, Union Therapeutics, Novartis, Jansen, Avita, and Galderma, has been an investigator for Lenicura, Pfizer, Incyte, Avita, and Loreal/Laroche Posay, and is a board member and past-president of the HS Foundation and Global Vitiligo Foundation. There was no financial transaction for the preparation of this manuscript. All other authors report no conflicts of interest.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors. The databases used in this study are publicly available: MEDLINE: and Embase: .